Latest filing published 09 Mar 2021 for Apollo Endosurgery, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew S. Crawford: trading record in brief
Matthew S. Crawford appears in our data through filings on Apollo Endosurgery, Inc. shares, published by SEC (Form 4). We count 31 filings; the first trade dates from 29 December 2016 and the latest from 24 February 2021.
The open-market record is one-sided, with 6 purchases worth €7.7M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €324k. 5 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 9 March 2021: a transaction, in Apollo Endosurgery, Inc. The most recent open-market purchase was published on 22 June 2018, 3,062 days ago. Typically, a trade is published a median of 13 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew S. Crawford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 857,964 sharesCommon StockSEC:0001104659-21-033849:1
- 857,964 sharesCommon StockSEC:0001104659-21-033849:2
- 857,964 sharesCommon StockSEC:0001104659-21-033849:3
- 857,964 sharesCommon StockSEC:0001104659-21-033849:4
- 857,964 sharesCommon StockSEC:0001104659-21-033849:5
- 1,347,565 sharesCommon StockSEC:0001104659-21-033849:6
- 13,473 sharesCommon StockSEC:0001104659-21-033849:7
- 13,473 sharesCommon StockSEC:0001104659-21-033849:8
- 4,444 sharesCommon StockSEC:0001104659-21-033849:9
- 605,712 sharesCommon StockSEC:0001104659-21-033849:10
- 6,055 sharesCommon StockSEC:0001104659-21-033849:11
- 6,055 sharesCommon StockSEC:0001104659-21-033849:12
- 2,017 sharesCommon StockSEC:0001104659-21-033849:13
- 857,964 sharesCommon StockSEC:0001104659-21-033849:0
- 1,341,222 sharesCommon StockSEC:0000899243-20-016874:0
- 245,444 sharesCommon StockSEC:0000899243-20-016874:1
- 245,444 sharesCommon StockSEC:0000899243-20-016874:2
- 74,218 sharesCommon StockSEC:0000899243-20-016874:3
- 363,500 shares@ US$5.5022.5% of flowCommon SockSEC:0001251769-18-000075:0Canonical exit: 18 Sept 2018 (T+90)
- 4,038 shares@ US$6.200.3% of flowCommon StockSEC:0001251769-18-000027:0Canonical exit: 7 Jun 2018 (T+90)
- 1,266,909 sharesCommon StockSEC:0000899243-17-027683:0
- 12,669 sharesCommon StockSEC:0000899243-17-027683:1
- 12,669 sharesCommon StockSEC:0000899243-17-027683:2
- 4,223 sharesCommon StockSEC:0000899243-17-027683:3
- 41,000 shares@ US$4.041.8% of flowCommon StockSEC:0000899243-17-022524:0Canonical exit: 4 Dec 2017 (T+90)
25 of 28 declarations